Back to companies

Novonesis

DKNasdaq CopenhagenPharmaceuticals & Healthcare

Novonesis

Revenue
DKK 17.6bn
FY2022
Operating income
—
FY2022
Employees
—
Founded
2000

Source: Wikidata (CC0)